CTLTUnknown

Catalent, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Catalent, Inc. (CTLT), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are CTLT insiders buying or selling?

Catalent, Inc. insiders reported 9 open-market buys ($4.8M) and 163 sells ($1.1B) across 172 Form 4 filings — a net selling position of $1.1B.

Source: SEC EDGAR Form 4

Key Statistics (as of Nov 14, 2024)

Total Form 4 filings
172
SEC EDGAR
Insider filers
34
Insider buys (9)
$4.8M
Insider sells (163)
$1.1B

Insider sentiment

Net selling

Net insider flow of $1.1B in net selling.

Recent CTLT insider transactions

DateInsiderRoleTypeSharesPriceValue
Nov 14, 2024Michelle R RyanDirectorSale2.8K$59.70$167.2K
Oct 21, 2024Joseph Anthony FerraroSVP, General Counsel, CCOSale320$59.97$19.2K
Sep 27, 2024David McerlaneGroup President, BiologicsSale2.0K$59.97$119.6K
Aug 5, 2024Ricky HopsonPres. BioProduct Delivery, CoSSale662$59.56$39.4K
Aug 5, 2024Scott GuntherSVP, Quality & Reg. AffairsSale666$59.55$39.7K
Aug 5, 2024Joseph Anthony FerraroSVP, General Counsel, CCOSale608$59.58$36.2K
Aug 5, 2024Lisa EvoliSVP, Chief HR OfficerSale3.9K$59.67$230.3K
Aug 5, 2024Aristippos GennadiosGroup Pres. Pharma & ConsumerSale1.2K$59.55$69.6K
Jul 30, 2024Alessandro MaselliPresident & CEOSale9.1K$58.76$534.0K
Jul 30, 2024Ricky HopsonPres. BioProduct Delivery, CoSSale206$58.67$12.1K
Jul 30, 2024Scott GuntherSVP, Quality & Reg. AffairsSale283$58.69$16.6K
Jul 30, 2024Aristippos GennadiosGroup Pres. Pharma & ConsumerSale349$58.70$20.5K
Jul 10, 2024Matti MasanovichSVP, Chief Financial OfficerSale3.0K$56.74$169.8K
Jun 6, 2024Ricky HopsonPres. BioProduct Delivery, CoSSale1.4K$54.26$76.0K
Mar 19, 2024Scott GuntherSVP, Quality & Reg. AffairsSale387$56.20$21.7K
Sep 5, 2023Michelle R RyanDirectorPurchase1.0K$49.98$50.0K
Sep 1, 2023John J GreischExecutive ChairPurchase21.0K$50.24$1.1M
Aug 25, 2023Alessandro MaselliPresident & CEOSale2.1K$44.54$92.2K
Aug 25, 2023Scott GuntherSVP, Quality & Reg. AffairsSale269$44.57$12.0K
Aug 25, 2023Michael J GrippoSVP, Strategy & Corp. Dev.Sale390$44.50$17.4K
Aug 25, 2023Aristippos GennadiosGroup Pres. Pharma & ConsumerSale396$44.49$17.6K
Aug 25, 2023Steven L FasmanEVP & Chief Admin OfficerSale817$44.65$36.5K
Aug 25, 2023Lorenzo CarlettiSVP Global Ops Ph & Cons HlthSale216$44.71$9.7K
Aug 25, 2023Jonathan ArnoldSVP, CCO & Div. Head BioP Del.Sale87$44.87$3.9K
Aug 25, 2023Ricky HopsonPres. Clinical Dev Supply DivSale276$44.56$12.3K

Showing the 25 most recent of 172 Form 4 filings for Catalent, Inc..

Most active CTLT insiders

  • Steven L Fasman15 filings
  • Scott Gunther14 filings
  • Aristippos Gennadios13 filings
  • Michael J Grippo13 filings
  • Ricky Hopson11 filings

Ask anything about CTLT insider activity

Use Trabud's AI agent to query Catalent, Inc.'s Form 4 history in plain English — "Show me CTLT CEO purchases this year" or compare it against any other ticker.

Open the AI agent

CTLT insider trading FAQ

Are Catalent, Inc. insiders buying or selling?

Across 172 SEC Form 4 filings, Catalent, Inc. (CTLT) insiders reported 9 open-market purchases totaling $4.8M and 163 sales totaling $1.1B. That is a net selling position of $1.1B.

How many insiders trade CTLT stock?

34 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Catalent, Inc.. The most recent filing was accepted on Nov 14, 2024.

Where does Trabud get CTLT insider trading data?

All CTLT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content